Maxim Group assumed coverage on shares of Vsee Health (NASDAQ:VSEE – Free Report) in a research note published on Monday, MarketBeat reports. The firm issued a buy rating and a $5.00 price target on the stock.
Vsee Health Price Performance
Shares of NASDAQ:VSEE opened at $1.51 on Monday. The stock’s 50-day simple moving average is $1.56 and its two-hundred day simple moving average is $1.56. Vsee Health has a 52-week low of $1.12 and a 52-week high of $33.08. The company has a debt-to-equity ratio of 0.16, a current ratio of 0.37 and a quick ratio of 0.37.
Institutional Trading of Vsee Health
An institutional investor recently raised its position in Vsee Health stock. Geode Capital Management LLC grew its holdings in Vsee Health, Inc. (NASDAQ:VSEE – Free Report) by 56.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 67,549 shares of the company’s stock after acquiring an additional 24,245 shares during the period. Geode Capital Management LLC owned 1.87% of Vsee Health worth $92,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 1.01% of the company’s stock.
Vsee Health Company Profile
VSee Health, Inc is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.
See Also
- Five stocks we like better than Vsee Health
- What is a Dividend King?
- Buffett’s on the Sidelines – Should You Follow?
- Using the MarketBeat Dividend Tax Calculator
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- What is the S&P 500 and How It is Distinct from Other Indexes
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Vsee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vsee Health and related companies with MarketBeat.com's FREE daily email newsletter.